Home › Rectal Cancer › Washington › Seattle
Rectal Cancer clinical trials in Seattle, WA
9 studies for Rectal Cancer are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi away
Family Communications After Genetic Testing
RecruitingHealthy volunteers welcome
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- and 1 more
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RecruitingPhase 3
- Fred Hutchinson Cancer Center ( Site 0076), Seattle
Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
RecruitingObservational study
- Fred Hutch, Seattle
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Recruiting
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi away
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
RecruitingPhase 3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- Fred Hutch Cancer Center, Seattle
Rectal Cancer trials in other cities
- New York City, NY17 studies
- Boston, MA12 studies
- Houston, TX11 studies
- St. Louis, MO11 studies
- Columbus, OH10 studies
- Los Angeles, CA10 studies
- Tampa, FL9 studies
- Nashville, TN9 studies
- Rochester, MN8 studies
- Chicago, IL8 studies
- Aurora, CO8 studies
- Salt Lake City, UT8 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)49 studies
- Prostate Cancer42 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer39 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer30 studies
- Multiple Myeloma22 studies
- Myelodysplastic Syndromes21 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.